p53 and p53-derived fragments have been shown to aggregate in vitro (Silva et al., 2014), and several p53 mutants have been found as amyloid aggregates in tumor cell lines (Xu et al., 2011) and breast cancer biopsies (Levy et al., 2011). Here, TP53 is linked to breast carcinoma.